<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Irish JM</submitter><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>3135-42</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC1895530</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>108(9)</volume><pubmed_abstract>The B-cell receptor (BCR) transmits life and death signals throughout B-cell development, and altered BCR signaling may be required for survival of B-lymphoma cells. We used single-cell signaling profiles to compare follicular lymphoma (FL) B cells and nonmalignant host B cells within individual patient biopsies and identified BCR-mediated signaling events specific to lymphoma B cells. Expression of CD20, Bcl-2, and BCR light chain isotype (kappa or lambda) distinguished FL tumor B-cell and nontumor host B-cell subsets within FL patient biopsies. BCR-mediated signaling via phosphorylation of Btk, Syk, Erk1/2, and p38 occurred more rapidly in tumor B cells from FL samples than in infiltrating nontumor B cells, achieved greater levels of per-cell signaling, and sustained this level of signal</pubmed_abstract><journal>Blood</journal><pubmed_title>Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells.</pubmed_title><pmcid>PMC1895530</pmcid><funding_grant_id>CA 33399</funding_grant_id><funding_grant_id>N01-HV-281831</funding_grant_id><funding_grant_id>CA 34233</funding_grant_id><pubmed_authors>Czerwinski DK</pubmed_authors><pubmed_authors>Irish JM</pubmed_authors><pubmed_authors>Nolan GP</pubmed_authors><pubmed_authors>Levy R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells.</name><description>The B-cell receptor (BCR) transmits life and death signals throughout B-cell development, and altered BCR signaling may be required for survival of B-lymphoma cells. We used single-cell signaling profiles to compare follicular lymphoma (FL) B cells and nonmalignant host B cells within individual patient biopsies and identified BCR-mediated signaling events specific to lymphoma B cells. Expression of CD20, Bcl-2, and BCR light chain isotype (kappa or lambda) distinguished FL tumor B-cell and nontumor host B-cell subsets within FL patient biopsies. BCR-mediated signaling via phosphorylation of Btk, Syk, Erk1/2, and p38 occurred more rapidly in tumor B cells from FL samples than in infiltrating nontumor B cells, achieved greater levels of per-cell signaling, and sustained this level of signal</description><dates><release>2006-01-01T00:00:00Z</release><publication>2006 Nov</publication><modification>2025-05-29T19:19:31.56Z</modification><creation>2019-03-27T02:04:10Z</creation></dates><accession>S-EPMC1895530</accession><cross_references><pubmed>16835385</pubmed><doi>10.1182/blood-2006-02-003921</doi></cross_references></HashMap>